BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10978206)

  • 1. Apramides A-G, novel lipopeptides from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2000 Aug; 63(8):1106-12. PubMed ID: 10978206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Jiménez JI; Scheuer PJ
    J Nat Prod; 2001 Feb; 64(2):200-3. PubMed ID: 11430000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carmabins A and B, new lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Hooper GJ; Orjala J; Schatzman RC; Gerwick WH
    J Nat Prod; 1998 Apr; 61(4):529-33. PubMed ID: 9584405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumonoic acids, novel metabolites from a cyanobacterial assemblage of Lyngbya majuscula and Schizothrix calcicola.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Biggs J; Park PU; Paul VJ
    J Nat Prod; 1999 Mar; 62(3):464-7. PubMed ID: 10096859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula.
    Nogle LM; Okino T; Gerwick WH
    J Nat Prod; 2001 Jul; 64(7):983-5. PubMed ID: 11473443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micromide and guamamide: cytotoxic alkaloids from a species of the marine cyanobacterium Symploca.
    Williams PG; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2004 Jan; 67(1):49-53. PubMed ID: 14738385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ; Mooberry SL
    J Nat Prod; 2000 May; 63(5):611-5. PubMed ID: 10843570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and structure determination of lyngbyastatin 3, a lyngbyastatin 1 homologue from the marine cyanobacterium Lyngbya majuscula. Determination of the configuration of the 4-amino-2,2-dimethyl-3-oxopentanoic acid unit in majusculamide C, dolastatin 12, lyngbyastatin 1, and lyngbyastatin 3 from cyanobacteria.
    Williams PG; Moore RE; Paul VJ
    J Nat Prod; 2003 Oct; 66(10):1356-63. PubMed ID: 14575437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malyngamide 3 and cocosamides A and B from the marine cyanobacterium Lyngbya majuscula from Cocos Lagoon, Guam.
    Gunasekera SP; Owle CS; Montaser R; Luesch H; Paul VJ
    J Nat Prod; 2011 Apr; 74(4):871-6. PubMed ID: 21341718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Pangilinan R; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2001 Mar; 64(3):304-7. PubMed ID: 11277744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 1999 Dec; 62(12):1702-6. PubMed ID: 10654420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula.
    Luesch H; Yoshida WY; Moore RE; Paul VJ
    J Nat Prod; 2000 Oct; 63(10):1437-9. PubMed ID: 11076573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.
    Harrigan GG; Luesch H; Yoshida WY; Moore RE; Nagle DG; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
    J Nat Prod; 1998 Sep; 61(9):1075-7. PubMed ID: 9748368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grenadadiene and grenadamide, cyclopropyl-containing fatty acid metabolites from the marine cyanobacterium Lyngbya majuscula.
    Sitachitta N; Gerwick WH
    J Nat Prod; 1998 May; 61(5):681-4. PubMed ID: 9599279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix species.
    Sitachitta N; Williamson RT; Gerwick WH
    J Nat Prod; 2000 Feb; 63(2):197-200. PubMed ID: 10691708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.
    McPhail KL; Correa J; Linington RG; Gonzalez J; Ortega-Barría E; Capson TL; Gerwick WH
    J Nat Prod; 2007 Jun; 70(6):984-8. PubMed ID: 17441769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three new malyngamides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula.
    McPhail KL; Gerwick WH
    J Nat Prod; 2003 Jan; 66(1):132-5. PubMed ID: 12542362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dragonamides C and D, linear lipopeptides from the marine cyanobacterium brown Lyngbya polychroa.
    Gunasekera SP; Ross C; Paul VJ; Matthew S; Luesch H
    J Nat Prod; 2008 May; 71(5):887-90. PubMed ID: 18393465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.
    Harrigan GG; Yoshida WY; Moore RE; Nagle DG; Park PU; Biggs J; Paul VJ; Mooberry SL; Corbett TH; Valeriote FA
    J Nat Prod; 1998 Oct; 61(10):1221-5. PubMed ID: 9784156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culture of the marine cyanobacterium, Lyngbya majuscula (Oscillatoriaceae), for bioprocess intensified production of cyclic and linear lipopeptides.
    Burja AM; Abou-Mansour E; Banaigs B; Payri C; Burgess JG; Wright PC
    J Microbiol Methods; 2002 Feb; 48(2-3):207-19. PubMed ID: 11777570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.